Takara Bio (TSE:4974) Moat Score: 0/10 (As of Jul. 11, 2026)


TSE:4974 Takara Bio Inc TSE:4974
50 GF Score
Price 円1,144.00
GF Value 円860.39
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Takara Bio Moat Score?

Takara Bio has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Takara Bio has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Takara Bio might have No Moat - No discernible moat.

Takara Bio  (TSE:4974) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Takara Bio Moat Score Related Terms

TSE:4974
50GF Score
Takara Bio Inc TSE:4974
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Takara Bio (TSE:4974) Overvalued in 2026?

Based on GuruFocus' analysis, Takara Bio stock appears to be overvalued. The current stock price of 円1,144.00 is trading 33% above its estimated GF Value™ of 円860.39. GuruFocus considers Takara Bio to be Significantly Overvalued.

Key valuation signals for TSE:4974:

  • Moat Score: 0
  • GF Value™: 円860.39 vs. price of 円1,144.00 (33% above fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the TSE:4974 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Takara Bio Business Description

Other Exchanges TF2:Germany
Address Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
50GF Score

Get the complete analysis for TSE:4974

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,144.00
Price
円860.39
GF Value